Cardiff Oncology Announces $10 Million Registered Direct Offering

Cardiff Oncology (NASDAQ:CRDF) announced a registered direct offering expected to raise approximately $10 million in gross proceeds. The funds will be used for working capital and general corporate purposes as the company advances its lead oncology program, onvansertib.

By Fiona Craig Wed, July 15, 2026 at 5:54 PM GMT+3 2 min read · Yahoo Finance · July 15, 2026, 14:54 UTC

Cardiff Oncology Announces $10 Million Registered Direct Offering

Tickers: $CRDF

Topics: registered direct offering stock financing working capital

Read the full article at Yahoo Finance

More World news

UBS Upgrades Rivian to Buy Rating Amid R2 Potential Motley Fool · November 12, 2026, 16:45 UTC
Stifel Downgrades EVgo to Hold Amid Weakening Growth Outlook Seeking Alpha · November 12, 2026, 16:41 UTC
Rowan Digital Infrastructure Secures Over $1.5 Billion in New Financing Seeking Alpha · November 12, 2026, 16:42 UTC
CAE Reports Q2 2027 Results with Increased EPS Guidance and Strong Defense Growth Motley Fool · November 12, 2026, 16:39 UTC
Alvotech Reports Q3 2026 Financial Results Amid Manufacturing Recovery Motley Fool · November 12, 2026, 16:39 UTC
Jacobs Solutions Declares Quarterly Dividend of $0.36 Per Share Seeking Alpha · November 12, 2026, 16:39 UTC
SOLV Energy Raises Revenue Guidance Following Record Q3 Project Execution Seeking Alpha · November 12, 2026, 16:40 UTC
LiveWorld Reports Q3 Revenue of $2.98 Million and GAAP EPS of -$0.01 Seeking Alpha · November 12, 2026, 16:37 UTC
Jensen Huang Resigns as Nvidia CEO Amid Allegations of Chinese Espionage The Verge · November 12, 2026, 16:30 UTC
Rising New Vehicle Monthly Payments Pose Affordability Risks for Ford and General Motors Motley Fool · November 12, 2026, 16:33 UTC